Brief: Avalon Globocare Signs MoU With Lu Daopei Hematology Institute To Develop Companion Diagnostics For Cellular Therapy

Change Agents

18/05/2022 14:33

May 18 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE SIGNS MOU TO FORM STRATEGIC PARTNERSHIP
WITH LU
DAOPEI HEMATOLOGY INSTITUTE TO DEVELOP PRECISION COMPANION
DIAGNOSTICS FOR CELLULAR THERAPY
    * AVALON GLOBOCARE CORP- SIGNED MOU WITH LU DAOPEI
HEMATOLOGY
INSTITUTE TO CO-DEVELOP PRECISION COMPANION DIAGNOSTICS FOR
CAR-T CELL THERAPIES

Source text for Eikon:  ID:nGNXPQbZY 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))